Novo Nordisk boosts sales and profit outlook, buoyed by Ozempic and Wegovy

Brighter projections may suggest more supply of popular weight-loss drugs by year end, analysts say.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.